266
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Renal tight junction proteins are decreased in cisplatin-induced nephrotoxicity in rats

, , , , , , , , & show all
Pages 520-528 | Received 19 May 2014, Accepted 21 Jul 2014, Published online: 11 Aug 2014

References

  • Arreola-Mendoza L, Del Razo LM, Mendoza-Garrido ME, et al. (2009). The protective effect of alpha-tocopherol against dichromate-induced renal tight junction damage is mediated via ERK1/2. Toxicol Lett 191:279–88
  • Bonventre JV. (2009). Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transpl 24:3265–8
  • Charlton JR, Portilla D, Okusa MD. (2014). A basic science view of acute kidney injury biomarkers. Nephrol Dial Transpl 29:1301–11
  • Chirino YI, Trujillo J, Sanchez-Gonzalez DJ, et al. (2008). Selective iNOS inhibition reduces renal damage induced by cisplatin. Toxicol Lett 176:48–57
  • Enck AH, Berger UV, Yu AS. (2001). Claudin-2 is selectively expressed in proximal nephron in mouse kidney. Am J Physiol Renal Physiol 281:F966–74
  • Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM. (1998). The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 273:29745–53
  • Furuse M, Fujita K, Hiiragi T, et al. (1998). Claudin-1 and-2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141:1539–50
  • Furuse M, Hirase T, Itoh M, et al. (1993). Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123:1777–88
  • Gonzalez-Mariscal L, Namorado MC, Martin D, et al. (2000). Tight junction proteins ZO-1, ZO-2, and occludin along isolated renal tubules. Kidney Int 57:2386–402
  • Gonzalez-Mariscal L, Tapia R, Chamorro D. (2008). Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778:729–56
  • Guerrero-Beltran CE, Calderon-Oliver M, Tapia E, et al. (2010). Sulforaphane protects against cisplatin-induced nephrotoxicity. Toxicol Lett 192:278–85
  • Guerrero-Beltran CE, Mukhopadhyay P, Horvath B, et al. (2012). Sulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathy. J Nutr Biochem 23:494–500
  • Hou J, Rajagopal M, Yu AS. (2013). Claudins and the kidney. Annu Rev Physiol 75:479–501
  • Ikeda S, Fukuzaki A, Kaneto H, et al. (1999). Role of protein kinase C in cisplatin nephrotoxicity. Int J Urol 6:245–50
  • Imamdi R, de Graauw M, van de Water B. (2004). Protein kinase C mediates cisplatin-induced loss of adherens junctions followed by apoptosis of renal proximal tubular epithelial cells. J Pharmacol Exp Ther 311:892–903
  • Jacquillet G, Barbier O, Cougnon M, et al. (2006). Zinc protects renal function during cadmium intoxication in the rat. Am J Physiol Renal Physiol 290:F127–37
  • Kitada M, Koya D, Sugimoto T, et al. (2003). Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes 52:2603–14
  • Kiuchi-Saishin Y, Gotoh S, Furuse M, et al. (2002). Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol 13:875–86
  • Koda R, Zhao L, Yaoita E, et al. (2011). Novel expression of claudin-5 in glomerular podocytes. Cell Tissue Res 343:637–48
  • Kuhad A, Pilkhwal S, Sharma S, et al. (2007). Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. J Agric Food Chem 55:10150–5
  • Kuhlmann MK, Burkhardt G, Kohler H. (1997). Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transpl 12:2478–80
  • Kwon O, Myers BD, Sibley R, et al. (1998). Distribution of cell membrane-associated proteins along the human nephron. J Histochem Cytochem 46:1423–34
  • McCarthy KM, Skare IB, Stankewich MC, et al. (1996). Occludin is a functional component of the tight junction. J Cell Sci 109:2287–98
  • Meyer TN, Schwesinger C, Ye J, et al. (2001). Reassembly of the tight junction after oxidative stress depends on tyrosine kinase activity. J Biol Chem 276:22048–55
  • Pan H, Mukhopadhyay P, Rajesh M, et al. (2009). Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death. J Pharmacol Exp Ther 328:708–14
  • Perez-Rojas JM, Cruz C, Garcia-Lopez P, et al. (2009). Renoprotection by alpha-Mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity. Free Radic Res 43:1122–32
  • Ramesh G, Reeves WB. (2002). TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110:835–42
  • Reyes JL, Lamas M, Martin D, et al. (2002). The renal segmental distribution of claudins changes with development. Kidney Int 62:476–87
  • Rosenthal R, Milatz S, Krug SM, et al. (2010). Claudin-2, a component of the tight junction, forms a paracellular water channel. J Cell Sci 123:1913–21
  • Sahin K, Tuzcu M, Sahin N, et al. (2010). Nrf2/HO-1 signaling pathway may be the prime target for chemoprevention of cisplatin-induced nephrotoxicity by lycopene. Food Chem Toxicol 48:2670–4
  • Saitou M, Ando-Akatsuka Y, Itoh M, et al. (1997). Mammalian occludin in epithelial cells: its expression and subcellular distribution. Eur J Cell Biol 73:222–31
  • Vaidya VS, Ramirez V, Ichimura T, et al. (2006). Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 290:F517–29
  • van Angelen AA, Glaudemans B, van der Kemp AW, et al. (2013). Cisplatin-induced injury of the renal distal convoluted tubule is associated with hypomagnesaemia in mice. Nephrol Dial Transpl 28:879–89
  • Wen H, Watry DD, Marcondes MC, Fox HS. (2004). Selective decrease in paracellular conductance of tight junctions: role of the first extracellular domain of claudin-5. Mol Cell Biol 24:8408–17

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.